Lineage Cell Therapeutics, Inc. financial data

Symbol
LCTX on NYSE
Location
Carlsbad, CA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 05 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 438% % 53%
Debt-to-equity 111% % 124%
Return On Equity -135% % -405%
Return On Assets -63% % -255%
Operating Margin -252% % -11%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 249,087,529 shares 9.1%
Common Stock, Shares, Outstanding 243,121,801 shares 10%
Entity Public Float $161,500,000 USD 10%
Common Stock, Value, Issued $515,467,000 USD 6.3%
Weighted Average Number of Shares Outstanding, Basic 230,116,000 shares 15%
Weighted Average Number of Shares Outstanding, Diluted 230,116,000 shares 15%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $14,556,000 USD 53%
Revenue from Contract with Customer, Excluding Assessed Tax $14,556,000 USD 53%
Cost of Revenue $272,000 USD -58%
Research and Development Expense $17,729,000 USD 42%
General and Administrative Expense $18,460,000 USD 1.6%
Costs and Expenses $51,175,000 USD 65%
Operating Income (Loss) $36,619,000 USD -70%
Nonoperating Income (Expense) $32,028,000 USD -1206%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $18,582,000 USD 20%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $63,533,000 USD -241%
Earnings Per Share, Basic -0.28 USD/shares -211%
Earnings Per Share, Diluted -0.28 USD/shares -211%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $40,791,000 USD -11%
Marketable Securities, Current $14,990,000 USD 644%
Accounts Receivable, after Allowance for Credit Loss, Current $891,000 USD 40%
Assets, Current $59,157,000 USD 16%
Deferred Income Tax Assets, Net $5,800,000 USD
Property, Plant and Equipment, Net $2,566,000 USD 14%
Operating Lease, Right-of-Use Asset $2,131,000 USD -0.61%
Intangible Assets, Net (Excluding Goodwill) $31,700,000 USD -32%
Goodwill $10,672,000 USD 0%
Assets $112,584,000 USD -0.56%
Accounts Payable, Current $2,341,000 USD 99%
Employee-related Liabilities, Current $3,744,000 USD 22%
Accrued Liabilities, Current $1,096,000 USD -8.4%
Contract with Customer, Liability, Current $10,100,000 USD -72%
Liabilities, Current $11,367,000 USD -19%
Deferred Income Tax Liabilities, Net $22,000 USD -92%
Operating Lease, Liability, Noncurrent $1,534,000 USD 18%
Liabilities $69,238,000 USD 91%
Accumulated Other Comprehensive Income (Loss), Net of Tax $3,920,000 USD -36%
Retained Earnings (Accumulated Deficit) $466,998,000 USD -16%
Stockholders' Equity Attributable to Parent $44,549,000 USD -43%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $43,346,000 USD -44%
Liabilities and Equity $112,584,000 USD -0.56%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $4,886,000 USD 16%
Net Cash Provided by (Used in) Financing Activities $5,044,000 USD -64%
Net Cash Provided by (Used in) Investing Activities $1,903,000 USD
Common Stock, Shares Authorized 450,000,000 shares 0%
Common Stock, Shares, Issued 243,121,801 shares 10%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $1,988,000 USD -76%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $41,324,000 USD -11%
Interest Paid, Excluding Capitalized Interest, Operating Activities $14,000 USD 600%
Deferred Tax Assets, Valuation Allowance $89,417,000 USD 3.6%
Deferred Tax Assets, Gross $109,522,000 USD 17%
Operating Lease, Liability $2,350,000 USD -1.8%
Payments to Acquire Property, Plant, and Equipment $97,000 USD 155%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $64,577,000 USD -251%
Operating Lease, Liability, Current $816,000 USD -26%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure -6.2%
Deferred Income Tax Expense (Benefit) $0 USD
Deferred Tax Assets, Operating Loss Carryforwards $70,637,000 USD 3.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 2,000,000 shares 0%
Unrecognized Tax Benefits $3,307,000 USD 4.9%
Operating Lease, Payments $305,000 USD 0.99%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $0 USD -100%
Deferred Tax Assets, Net of Valuation Allowance $20,105,000 USD 183%
Share-based Payment Arrangement, Expense $4,752,000 USD -6.4%